Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, E Marchioni, A Pesci, G Dei, MR Pozzi… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis

…, L Scussel Lonzetti, M Rosa Pozzi… - Arthritis & …, 2019 - Wiley Online Library
Objective Systemic sclerosis ( SS c) is a heterogeneous connective tissue disease that is
typically subdivided into limited cutaneous SS c (lc SS c) and diffuse cutaneous SS c (dc SS c) …

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

…, G Frontini, G Porata, P Fabbrini, MR Pozzi… - Journal of …, 2020 - Springer
Background Belimumab (Benlysta) is currently approved for the treatment of active Lupus
despite standard therapy. Few data are available on the efficacy of this drug in lupus nephritis (…

Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.

…, M Riva, LM Canziani, G Bianchi, MR Pozzi… - Clinical and …, 2020 - europepmc.org
Objectives Baricitinib, an oral Janus kinase (JAK) 1-2 inhibitor, is currently used along biologic
DMARDs (bDMARDs) after the failure of methotrexate (MTX) in rheumatoid arthritis (RA). …

[PDF][PDF] CTLA-4 regulates human Natural Killer cell effector functions

…, O Patrizi, L Gazzurelli, N Mitsuiki, MR Pozzi… - Clinical …, 2018 - iris.unibs.it
Cytotoxic T lymphocyte antigen 4 (CTLA-4) is a member of a family of immunoglobulin-related
receptors that includes CD28, Inducible T-cell costimulator (ICOS), Programmed cell …

Fatal SARS-CoV-2 infection in a male patient with Good's syndrome

MR Pozzi, M Baronio, MB Janetti… - Clinical …, 2020 - pmc.ncbi.nlm.nih.gov
Highlights This study describes for the first time the clinical course of SARS-CoV-2 infection
in a male patient with Good's syndrome. Absence of peripheral B cells may not always …

Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

…, S Ullman, CA von Mühlen, MR Pozzi… - The Lancet …, 2022 - thelancet.com
Background The current subclassification of systemic sclerosis into cutaneous subtypes does
not fully capture the heterogeneity of the disease. We aimed to compare the performances …

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

…, CP Denton, G Riemekasten, MR Pozzi… - …, 2015 - academic.oup.com
Objective. The aim of this study was to assess the prognostic value of systolic pulmonary
artery pressure (sPAP) estimated by echocardiography in the multinational European League …

Tandem linkage and unusual RNA splicing of the T-cell receptor beta-chain variable-region genes.

…, MC Louie, SA Godambe, MR Pozzi… - Proceedings of the …, 1987 - National Acad Sciences
The variable-region (V) genes of the murine T-cell receptor beta chain exist largely as single-element
subfamilies. The V beta 5 and V beta 8 genes belong to the only two known three-…

Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.

M Gardinali, MR Pozzi, M Bernareggi… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To evaluate the efficacy and safety of prostaglandin (PG) E1alpha-cyclodextrin
for Raynaud's phenomenon (RP) secondary to systemic sclerosis (SSc) and its effect on …